AI-generated content for informational purposes only. Not financial advice. Always do your own research.

À propos

Intuitive Surgical, Inc. (NASDAQ: ISRG) est le leader mondial de la chirurgie mini-invasive assistée par robot, mieux connue pour ses systèmes chirurgicaux da Vinci utilisés dans des millions d'interventions dans le monde dans les domaines de l'urologie, de la gynécologie, de la chirurgie cardiothoracique et de la chirurgie générale. L'entreprise génère des revenus récurrents à partir des instruments, des accessoires et des services liés à sa grande base installée de systèmes robotiques. Intuitive Surgical est une action de premier plan à l'intersection de la robotique et de la santé, offrant aux investisseurs une exposition à l'adoption croissante de la robotique chirurgicale avec une position dominante sur le marché et un modèle de revenu lame de rasoir.

Actions du vieillissement de la population

La plateforme de chirurgie robotique da Vinci d'Intuitive Surgical devient de plus en plus essentielle car le vieillissement des populations stimule la demande de procédures chirurgicales peu invasives avec des temps de récupération plus rapides.

Actions de la sante

Intuitive Surgical est une action de santé à l'intersection de la technologie médicale et de l'innovation, avec ses systèmes de chirurgie robotique da Vinci installés dans des hôpitaux du monde entier effectuant des millions de procédures peu invasives chaque année, générant des revenus récurrents à forte marge provenant des instruments, accessoires et contrats de service qui augmentent avec chaque système implanté.

Actions de robotique

Intuitive Surgical est l'action robotique dominante dans l'espace de l'automatisation chirurgicale, ses systèmes da Vinci définissant la norme pour la chirurgie assistée par robot. Son parc installé massif, ses revenus récurrents de consommables et son expansion vers de nouveaux types de procédures en font l'investissement robotique pur le plus important dans le domaine médical.

Key Financials ISRG

Prix $485.84
Variation (1J) +1.51%
Variation (30D) -14.22%
Variation (60D) -11.13%
Variation (90D) +8.04%
Variation (180D) -12.05%
Variation (1Y) -17.60%
Variation (5Y) +87.02%
P/E Ratio 71.45
EPS (TTM) $6.80
Plage sur 52 semaines $425.00 — $609.08
MA sur 50 jours $542.29
Volume 1.98M

Data updated Feb 15 · Source: Twelve Data

4.8
2 reviews
Demographic Exposure
4.8
Growth Potential
4.5
Financial Stability
4.2
Regulatory Risk
3.8
Dividend Reliability
2.5
Claude Opus 4.6
AI Review
4.6/5

Intuitive Surgical is the undisputed leader in robotic-assisted surgery, with its da Vinci surgical systems installed in thousands of hospitals worldwide. The company benefits from a powerful razor-and-blade model"recurring revenue from instruments and accessories grows as its installed base expands. With an EPS of $6.80 and strong procedure volume growth, fundamentals remain solid.

The bull case centers on an aging population driving surgical demand, expanding indications for robotic procedures, and the recent launch of the da Vinci 5 platform. Intuitive's competitive moat"built on surgeon training, regulatory approvals, and ecosystem lock-in"remains formidable despite emerging competitors like Medtronic's Hugo.

The bear case is valuation. At a P/E of 71.45, the stock prices in years of flawless execution. The recent 17.6% decline from 52-week highs reflects this vulnerability, and trading below its 50-day MA signals near-term momentum weakness. Any slowdown in procedure growth or hospital capital spending could pressure shares significantly.

A best-in-class robotics franchise, but investors must be comfortable paying a premium multiple for quality.

Demographic Exposure
4.8
Growth Potential
4.5
Financial Stability
4.2
Regulatory Risk
3.8
Dividend Reliability
2.5
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.9/5

Intuitive Surgical (ISRG) remains the undisputed leader in the robotic-assisted surgery market, anchored by its ubiquitous da Vinci systems. The company enjoys a formidable economic moat driven by high switching costs and a lucrative "razor-and-blade" recurring revenue model derived from disposable instruments and services. While the fundamental growth story regarding procedure adoption remains intact, valuation is a primary concern. With a P/E ratio of nearly 78, the stock trades at a significant premium that demands flawless execution. Currently trading below its 50-day moving average of $547.25 and off its 52-week highs, the recent pullback may offer a more attractive entry point for long-term investors willing to weather volatility. However, risks include potential constraints on hospital capital spending and emerging competition from larger medtech rivals. ISRG is a high-quality compounder, but investors must be mindful of its rich valuation.

Feb 11, 2026

Latest from Otrai

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.

Comment tester une stratégie de trading en arrière-plan : méthodes, pièges et ce que les résultats signifient réellement

Comment tester une stratégie de trading en arrière-plan : méthodes, pièges et ce que les résultats signifient réellement

Chaque trader a une stratégie qui semble excellente dans sa tête. Le backtesting est la façon de découvrir si cela fonctionne réellement. Voici comment tester les stratégies correctement, quelles métriques comptent et pourquoi la plupart des résultats de backtesting sont trop beaux pour être vrais.